Clinical Pharmacology and Therapeutic Potential of Monoclonal Antibody Treatment in Rheumatoid Arthritis

被引：0
|
作者：
Ernest H. S. Choy
机构：
[1] Guy’s and King’s College Hospitals,Rheumatology Unit
[2] Guy’s Hospital,Rheumatology Unit, 5th Floor, Thomas Guy House
来源：
Drugs & Aging | 1998年 / 12卷
关键词：
Rheumatoid Arthritis; Adis International Limited; Synovial Fluid; Rheumatol; Synovial Joint;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many monoclonal antibodies (mAb) have been tested in rheumatoid arthritis (RA). Murine antibodies were antigenic and caused human antimouse responses in the recipients. As a result, re-treatments were less effective and were associated with an increased risk of anaphylaxis. Advances in biotechnology have allowed us to develop chimaeric and humanised mAb that are less antigenic than their murine equivalents.
引用
收藏
页码：139 / 148
页数：9
相关论文
共 50 条
  • [1] HUMANIZED MONOCLONAL-ANTIBODY TREATMENT IN RHEUMATOID-ARTHRITIS
    KYLE, V
    RODDY, J
    HALE, G
    HAZLEMAN, BL
    WALDMANN, H
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (11) : 1737 - 1738
  • [2] Monoclonal antibody therapy in rheumatoid arthritis
    Choy, EHS
    Kingsley, GH
    Panayi, GS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (05): : 484 - 490
  • [3] Monoclonal antibody treatments for rheumatoid arthritis
    Bossaller, Lukas
    Rothe, Achim
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1257 - 1272
  • [4] Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights
    Raimondo, Maria Gabriella
    Biggioggero, Martina
    Coletto, Lavinia Agra
    Ramming, Andreas
    Caporali, Roberto
    Favalli, Ennio Giulio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (06) : 661 - 670
  • [5] Monoclonal antibodies in the treatment of rheumatoid arthritis: toward a therapeutic revolution.
    Sany, Jacques
    COMPTES RENDUS BIOLOGIES, 2006, 329 (04) : 228 - 240
  • [6] MIF, a potential therapeutic target for rheumatoid arthritis?
    Zhaolin Chen
    Taotao Ma
    Cheng Huang
    Lei Zhang
    Tingting Hu
    Jun Li
    Rheumatology International, 2014, 34 : 1481 - 1482
  • [7] THERAPEUTIC USE OF MONOCLONAL ANTI-CD4 ANTIBODY IN RHEUMATOID-ARTHRITIS
    WENDLING, D
    WIJDENES, J
    RACADOT, E
    MORELFOURRIER, B
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (03) : 325 - 327
  • [8] Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
    Huang, Jie
    Fu, Xuekun
    Chen, Xinxin
    Li, Zheng
    Huang, Yuhong
    Liang, Chao
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Therapeutic potential of Oroxylin A in rheumatoid arthritis
    Wang, Yu-ling
    Gao, Ju-mei
    Xing, Li-Zhi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 40 : 294 - 299
  • [10] Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies
    Wang, Qin
    Qin, Xianyan
    Fang, Jiyu
    Sun, Xun
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (05) : 1158 - 1174
12345